Assessing chronic pelvic pain syndrome patients: Blood plasma factors and cortisol saliva

Scandinavian Journal of Urology

Volumn 47, Issue 6, 2013, Pages 521-528

  Lundh, Dan ^a   Hedelin, Hans ^b   Jonsson, Karin ^c   Gifford, Mervyn ^a   Larsson, Dennis ^a  

^a UNIVERSITY OF SKÖVDE   (Sweden)

^b SKARABORG HOSPITAL   (Sweden)

^c Research and Development Centre   (Sweden)

Author keywords

Blood plasma; Chronic pelvic pain syndrome; Macrophage migration inhibitory factor

Indexed keywords

CYCLOOXYGENASE 2; GAMMA INTERFERON; HYDROCORTISONE; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; MACROPHAGE MIGRATION INHIBITION FACTOR; MATRIX METALLOPROTEINASE; NITRIC OXIDE; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CARDIOVASCULAR SYSTEM; CHRONIC PROSTATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; IMMUNE RESPONSE; MALE; MIDDLE AGED; PAIN ASSESSMENT; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SALIVA LEVEL; TESTOSTERONE BLOOD LEVEL;

ADULT; AGED; CASE-CONTROL STUDIES; CHRONIC DISEASE; COMORBIDITY; CYTOKINES; HUMANS; HYDROCORTISONE; INTERLEUKIN-1BETA; INTERLEUKIN-2; INTRAMOLECULAR OXIDOREDUCTASES; LYMPHOTOXIN-ALPHA; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; PELVIC PAIN; PROSTATITIS; SALIVA; SYNDROME; TESTOSTERONE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84890518365     PISSN: 21681805     EISSN: 21681813     Source Type: Journal    
DOI: 10.3109/21681805.2013.769460     Document Type: Article

References (37)

1. Schaeffer AJ. Epidemiology and demographics of prostatitis. Andrologia 2003;35:252-7.
2. Alexander RB. Treatment of chronic prostatitis. Nat Clin Pract Urol 2004;1:2-3.
3. Hedelin H, Fall M. Controversies in chronic abacterial prostatitis/pelvic pain syndrome. Scand J Urol Nephrol 2008;42:198-204.
4. Clemens JQ, Nadler RB, Schaeffer AJ, Belani J, Albaugh J, Bushman W. Biofeedback, pelvic floor re-education, and bladder training for male chronic pelvic pain syndrome. Urology 2000;56:951-5.
5. Shoskes DA, Nickel JC, Dolinga R, Prots D. Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. Urology 2009;73:538-42; discussion 42-3.
6. Alexander RB, Ponniah S, Hasday J, Hebel JR. Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. Urology 1998;52:744-9.
7. Aloisi AM, Pari G, Ceccarelli I, Vecchi I, Ietta F, Lodi L, et al. Gender-related effects of chronic non-malignant pain and opioid therapy on plasma levels of macrophage migration inhibitory factor (MIF). Pain 2005;115:142-51.
8. Pontari MA, Ruggieri MR. Mechanisms in prostatitis/ chronic pelvic pain syndrome. J Urol 2008;179:S61-7.
9. Hochreiter WW, Nadler RB, Koch AE, Campbell PL, Ludwig M, Weidner W, et al. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology 2000;56:1025-9.
10. Khadra A, Fletcher P, Luzzi G, Shattock R, Hay P. Interleukin-8 levels in seminal plasma in chronic prostatitis/ chronic pelvic pain syndrome and nonspecific urethritis. BJU Int 2006;97:1043-6.
11. Penna G, Mondaini N, Amuchastegui S, Degli Innocenti S, Carini M, Giubilei G, et al. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia. Eur Urol 2007;51:524-33.
12. He L, Wang Y, Long Z, Jiang C. Clinical significance of IL-2, IL-10, and TNF-[alpha] in prostatic secretion of patients with chronic prostatitis. Urology 2010;75:654-7.
13. Duan Z-G, Yang W-M. Analysis of cytokines (IL-2, IL-8, IL-10) in the expressed prostatic secretions of chronic prostatitis. Zhonghua Nan Ke Xue 2005;11:201-3.
14. Miller LJ, Fischer KA, Goralnick SJ, Litt M, Burleson JA, Albertsen P, et al. Interleukin-10 levels in seminal plasma: implications for chronic prostatitis-chronic pelvic pain syndrome. J Urol 2002;167:753-6.
15. Desireddi NV, Campbell PL, Stern JA, Sobkoviak R, Chuai S, Shahrara S, et al. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-1[alpha] as possible biomarkers for the chronic pelvic pain syndrome. J Urol 2008;179:1857-62.
16. Aghazarian A, Plas E, Stancik I, Pflüger H, Lackner J. New method for differentiating chronic prostatitis/chronic pelvic pain syndrome IIIA from IIIB involving seminal macrophages and monocytes. Urology 2011;78:918-23.
17. Dimitrakov J, Joffe HV, Soldin SJ, Bolus R, Buffington CAT, Nickel JC. Adrenocortical hormone abnormalities in men with chronic prostatitis/chronic pelvic pain syndrome. Urology 2008;71:261-6.
18. Grieb G, Merk M, Bernhagen J, Bucala R. Macrophage migration inhibitory factor (MIF): a promising biomarker. Drug News Perspect 2010;23:257-64.
19. Vania Apkarian A, Lavarello S, Randolf A, Berra HH, Chialvo DR, Besedovsky HO, et al. Expression of IL-1[beta] in supraspinal brain regions in rats with neuropathic pain. Neurosci Lett 2006;407:176-81.
20. Korner H, Sedgwick JD. Tumour necrosis factor and lymphotoxin: molecular aspects and role in tissue-specific autoimmunity. Immunol Cell Biol 1996;74:465-72.
21. Anderson RU, Orenberg EK, Morey A, Chavez N, Chan CA. Stress induced hypothalamus-pituitary-adrenal axis responses and disturbances in psychological profiles in men with chronic prostatitis/chronic pelvic pain syndrome. J Urol 2009;182:2319-24.
22. Reiche EMV, Nunes SOV, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol 2004;5:617-25.
23. Dantzer R, Kelley KW. Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci 1989;44:1995-2008.
24. Yao MZ, Gu JF, Wang JH, Sun LY, Lang MF, Liu J, et al. Interleukin-2 gene therapy of chronic neuropathic pain. Neuroscience 2002;112:409-16.
25. Musil R, Schwarz MJ, Riedel M, Dehning S, Cerovecki A, Spellmann I, et al. Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression - no influence of celecoxib treatment. J Affect Disord 2011;134:217-25.
26. Nickel JC, Downey J, Hunter D, Clark J. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health Chronic Prostatitis Symptom Index. J Urol 2001;165:842-5.
27. Whiteman M, Chu SH, Siau JL, Rose P, Sabapathy K, Schantz JT, et al. The pro-inflammatory oxidant hypochlorous acid induces Bax-dependent mitochondrial permeabilisation and cell death through AIF-/EndoG-dependent pathways. Cell Signal 2007;19:705-14.
28. Malemud CJ. Growth hormone, VEGF and FGF: involvement in rheumatoid arthritis. Clin Chim Acta 2007;375:10-19.
29. Blanco LE, de Serres FJ, Fernandez-Bustillo E, Kassam DA, Arbesu D, Rodriguez C, et al. a1-Antitrypsin and fibromyalgia: new data in favour of the inflammatory hypothesis of fibromyalgia. Med Hypotheses 2005;64:759-69.
30. Thompson ME, Barkhuizen A. Fibromyalgia, hepatitis C infection, and the cytokine connection. Curr Pain Headache Rep 2003;7:342-7.
31. Kivioja J, Ozenci V, Rinaldi L, Kouwenhoven M, Lindgren U, Link H. Systemic immune response in whiplash injury and ankle sprain: elevated IL-6 and IL-10. Clin Immunol 2001;101:106-12.
32. Rosendal L, Kristiansen J, Gerdle B, Sogaard K, Peolsson M, Kjaer M, et al. Increased levels of interstitial potassium but normal levels of muscle IL-6 and LDH in patients with trapezius myalgia. Pain 2005;119:201-9.
33. Moalem G, Tracey DJ. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev 2006;51:240-64.
34. Weidner W, Anderson RU. Evaluation of acute and chronic bacterial prostatitis and diagnostic management of chronic prostatitis/chronic pelvic pain syndrome with special reference to infection/inflammation. Int J Antimicrob Agents 2008;31:91-5.
35. Litwin MS. A review of the development and validation of the National Institutes of Health Chronic Prostatitis Symptom Index. Urology 2002;60:14-18; discussion 8-9.
36. Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J, et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci USA 2002;99:345-50.
37. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999;79: 1193-226.